Of note, the vast majority of tumor cells were cleared from PB at timepoint V6 (Fig. 1d), but with scRNA-seq, we were able to detect a single tumor cell in sample V6 and this tumor cell harbored the CCND1 E36K mutation, a mutation that associated with ibrutinib resistance52. This evidence concerns the gene CCND1 and neoplasm.